Discover® Global Network Study Shows 85% of Consumers are Less Likely to Interact with a Business Due to a Poor Payment Experience
3.6.2024 09:00:00 EEST | Business Wire | Press release
Discover Global Network®, a leading global payment network, released the first portion of the 2024 Payment State of the Union (PSOU), one of the most comprehensive studies of its kind in the industry, providing global perspectives from merchants and consumers. The research study, commissioned by Discover Global Network with S&P Global Market Intelligence’s 451 Research, uncovers key insights into merchant payment trends in response to customer payment priorities, merchant pain points and advancements in digital payments. At Money 20/20 Europe, Discover Global Network will share a first look at the PSOU results, highlighting emerging trends in the industry from global merchants and consumers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240602256326/en/
Payments are at the heart of omni-channel success (Graphic: Business Wire)
Here are key takeaways from respondents in this new study:
- Payment Diversification Can Drive Competitive Differentiation for Merchants
- Merchants see value in a seamless payment experience: Nearly two out of three (61%) merchants say payments are a highly strategic area of focus that drives significant competitive differentiation.
-
Merchants see an assortment of digital payment options as a key driver: More than half of merchants (53%) said offering a variety of digital payment options is the top strategy for driving conversions, highlighting the need for diverse payment integration for a personalized payments experience.
- Consumers agree with merchants: the ability to pay using a preferred payment method is the most significant factor (63% strongly agree) influencing consumers to complete a purchase.
- Merchants realize there is room for improvement: Less than one out of four (23%) merchants believe they are providing highly engaging digital experiences for customers.
“We’re seeing a continuing trend of merchants viewing payments as a driver for top- and bottom-line improvements, in addition to customer experience enhancements,” said Rajiv Gupta, vice president, international markets (EMEA) at Discover Global Network. “It’s no longer cash or credit as the two options. Our payment solutions can help merchants enable various options so consumers can pay using their preferred payment method.”
- Click and Mortar: Omnichannel Options are a Key Pain Point for Consumers and an Opportunity for Merchants
-
In-store payment experiences should not be overlooked: While most consumers globally (57%) expect to spend most of their discretionary income online this year, in-store purchases are rebounding, rising to 43% in 2024, up from 39% in 2023.
- Consumers in both North America and EMEA are driving in-store spend. More than half (55%) of consumers in North America and nearly half (48%) of consumers in EMEA expect to spend the majority of discretionary income in-store.
-
Consumers are frustrated by today’s omnichannel experience: Over the last six months, a lack of omnichannel options is the primary pain point consumers experienced after making a payment to businesses.
- Merchants recognize there’s work to be done as 86% agree their omnichannel payment experience needs improvement.
-
In-store payment experiences should not be overlooked: While most consumers globally (57%) expect to spend most of their discretionary income online this year, in-store purchases are rebounding, rising to 43% in 2024, up from 39% in 2023.
- Tap to Pay on Mobile and Integrated Checkout Experiences Are a Key Piece of the Future In-Store Experience
-
Merchants see tap to pay on mobile (92%) as the #2 two value driver for their organizations over the next three years.
- The benefits of Tap to pay on Mobile drives merchant interest: The ability to accept payments nearly anywhere (61%) and deliver a more personalized sales experience (56%) are the top two use cases driving merchant interest in the technology.
- Consumers enjoy ease of tap-to-pay on mobile: Nearly three out of four consumers (73%) are comfortable making an in-person payment by tapping their card or phone onto a merchant’s mobile device.
- Merchants are prioritizing unique checkout experiences: In addition, to convert more shoppers in-store, merchants are prioritizing ways to offer an integrated app checkout experience that combines payment, offers and rewards (43%), promote contactless payment options (39%) and offer more installment/financing options (39%).
-
Merchants see tap to pay on mobile (92%) as the #2 two value driver for their organizations over the next three years.
“With more consumers returning to in-store shopping, merchants have an opportunity to elevate their payment options to ensure they reflect the changing preferences of consumers," said Gupta. “Whether it’s tap on pay mobile or contactless payment options, Discover Global Network offers the payment tools and resources merchants need to help convert customer sales.”
Money 20/20 Europe
Discover’s Rajiv Gupta and 451 Research’s Jordan McKee will host an in-depth mainstage presentation to highlight the findings from the Payment State of the Union and what it reveals about the payments space and merchant/consumer needs.
- When: Tuesday, Jun. 4 10:30 AM Local Time
- Where: The Singularity Stage, RAI
- What: Enhancing the Payments Experience: Balancing Merchant & Consumer Needs
“This year’s survey revealed the value of payments for both merchants and consumers. Merchants are recognizing how diverse payment options can lead to higher conversions, while consumers are prioritizing payment methods tailored to their individual needs and requirements,” said Jordan McKee, Research Director of the fintech practice at 451 Research, part of S&P Global Market Intelligence. “With this in mind, a critical success factor for merchants is aligning with payments partners who understand the nuances of the global landscape and can connect them to the payment methods their customers expect to use.” 1
For a deeper dive into these findings, visit (or download) the full study.
Survey Methodology
A global survey of 5,030 consumer and 2,258 merchant respondents was commissioned by Discover Global Network and conducted by 451 Research, part of S&P Global Market Intelligence, an independent research firm, in Q1 2024. Markets surveyed include Brazil, Canada, mainland China/Hong Kong, Germany, India, Japan, Mexico, Singapore, the UK and the US.
About Discover
Discover Financial Services (NYSE: DFS) is a digital banking and payment services company with one of the most recognized brands in U.S. financial services. Since its inception in 1986, the company has become one of the largest card issuers in the United States. The company issues the Discover® card, America's cash rewards pioneer, and offers private student loans, personal loans, home loans, checking and savings accounts and certificates of deposit through its banking business. It operates the Discover Global Network® comprised of Discover Network, with millions of merchants and cash access locations; PULSE®, one of the nation's leading ATM/debit networks; and Diners Club International®, a global payments network with acceptance around the world. For more information, visit www.discover.com/company.
1 Enhancing the payment experience: Balancing merchant and consumer needs, S&P Global Market Intelligence 451 Research, 2024
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240602256326/en/
Contact information
Katie Gaynor
+1-513-478-0851
katiegaynor@discover.com
@Discover_News
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release
Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
